During the study, we identified seven new variants in four genes (IKZF1, IKZF3, WWOX, and ZPBP2), most of which were present in the ALL_NAT group, that is, Amerindian ALL patients. The gene discussed is ZPBP2; the disease is acute lymphoblastic leukemia.